PTIX
Protagenic Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.75
−1.64%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$4.48
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$0.53
- EPS estimate
- -$4.48
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +88.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$4.48 | -$0.53 | Beat 88.17% | — |
| Mar 9, 2026 | — | -$0.47 | — | — |
| Nov 26, 2025 | — | -$0.47 | — | — |
| Aug 18, 2025 | — | -$1.37 | — | — |
| Mar 31, 2025 | — | -$3.36 | — | — |
| Nov 14, 2024 | — | -$1.96 | — | — |
| Aug 14, 2024 | — | -$5.04 | — | — |
| May 15, 2024 | — | -$5.46 | — | — |
| Nov 14, 2023 | — | -$4.48 | — | — |
| Aug 14, 2023 | — | -$3.92 | — | — |
| May 15, 2023 | — | -$2.38 | — | — |
| Mar 31, 2023 | — | -$0.14 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026